Clinical Impact of <i>Staphylococcus aureus</i> Skin and Soft Tissue Infections
The pathogenic bacterium <i>Staphylococcus aureus</i> is the most common pathogen isolated in skin-and-soft-tissue infections (SSTIs) in the United States. Most <i>S. aureus</i> SSTIs are caused by the epidemic clone USA300 in the USA. These infections can be serious; in 2019...
Main Authors: | Matthew S. Linz, Arun Mattappallil, Diana Finkel, Dane Parker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/3/557 |
Similar Items
-
Proline Transport and Growth Changes in Proline Transport Mutants of <i>Staphylococcus aureus</i>
by: William R. Schwan
Published: (2022-09-01) -
<i>Staphylococcus aureus</i> in Polymicrobial Skinand Soft Tissue Infections: Impact of Inter-Species Interactionsin Disease Outcome
by: Florencia Mariani, et al.
Published: (2023-07-01) -
Molecular Epidemiologic and Geo-Spatial Characterization of <i>Staphylococcus aureus</i> Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City
by: Lilly Cheng Immergluck, et al.
Published: (2023-10-01) -
Clonal Lineages, Antimicrobial Resistance, and PVL Carriage of <i>Staphylococcus aureus</i> Associated to Skin and Soft-Tissue Infections from Ambulatory Patients in Portugal
by: Carolina Ferreira, et al.
Published: (2021-03-01) -
Characterization of community-associated Staphylococcus aureus from skin and soft-tissue infections: a multicenter study in China
by: Ying Liu, et al.
Published: (2016-01-01)